Origin Therapeutics

Origin is an actively-managed investment issuer focused in the psychedelic space. The management team, Board of Directors, and Advisors all have extensive experience in venture capital, and specifically markets like cannabis and existing psychedelic companies. 

Origin is helping people to invest across five key areas of psychedelic medicine:

• Clinical Drug Discovery and Development;

• Intellectual Property;

• Marketing/Advertising/Media;

• Therapeutic Centers; and

• Consumer Wellness Products

At present, Origin has signed five investment deals:

• Dimensions Health Centres
• MicroDose
• TripSitter
• Xpira Pharmaceuticals
• Ocean Bio